Article Details
Retrieved on: 2022-10-18 19:13:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Genetic engineering company Empyrean Neurosciences stepped into the CNS arena with $22 million and a small molecule platform derived from plants ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here